Work

285P Treatment patterns and clinical outcomes of germline BRCA mutation (gBRCAm)-associated breast cancer (BC): A matched, case-control study

Year: 2023

Type: article

Study design: Observational Study

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2023.09.482

Authors: S. Morganti, S.E. Kim, Q. Jin, J. Cha, J.E. Zeigler, A.B. Newman, J. Vincuilla, T. Parker, R. Buehler, E.A. Mittendorf, T.A. King, B. Bychkovsky, G. Curigliano, A.H. Partridge, N.U. Lin, J.E. Garber, N. Tayob, S.M. Tolaney, F. Lynce

Institutions: Dana-Farber Cancer Institute, Harvard University, Brigham and Women's Hospital, European Institute of Oncology

Language: English

Topic: BRCA gene mutations in cancer

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: American Society of Clinical Oncology, Genentech, Stand Up To Cancer

OpenAlex ID: W4387808712

FWCI:

Cites:

Cited by:

Related to: 10